Lifeline Biotechnologies Inc (LLBO)
Lifeline Biotechnologies Inc. is a healthcare company focused on medical technology for prevention, early diagnosis, and faster recovery from various diseases. The company’s products include First Warning System, a non-invasive device intended to help detect breast tissue abnormalities in women at an early stage. It also develops Mastascope, a handheld endoscope designed for use through a breast milk duct to allow visualization of internal breast structures, and OVASCOPE, an ultra-slim endoscope used to view the ovarian surface in the search for cancer. Lifeline Biotechnologies operates in the United States and Europe. The company was incorporated in 1981 and is headquartered in Reno, Nevada. Its common stock is quoted on OTC Markets under the symbol LLBO.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-LLBO
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
2.174 M
|
—
|
—
|
—
|
—
|
—
|
—
|